ClinConnect ClinConnect Logo
Search / Trial NCT04154514

A Potential Wearable for Post-stroke Rehabilitation

Launched by CHINESE UNIVERSITY OF HONG KONG · Nov 5, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new wearable device designed to help people who have had a stroke improve their walking ability. The device uses something called Functional Electrical Stimulation (FES) to gently stimulate muscles and help retrain them for better movement. Participants in this study will attend about 18 training sessions over a month, where they will learn how to use this technology to strengthen their walking skills and improve muscle coordination.

To be eligible for this trial, participants should be right-handed adults aged 40 or older who had a stroke at least six months ago and can walk for at least 15 minutes, even if they need some help. However, those with certain conditions, such as severe depression or diabetes, may not qualify. Throughout the trial, participants can expect to receive personalized guidance and support as they work to regain their walking abilities, and the goal is to help their walking patterns become more like those of healthy individuals over time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Right-handed elderly chronic stroke survivors; age ≥40; ≥6 months post-stroke
  • 2. Unilateral ischemic brain lesions
  • 3. Participants should be able to walk continuously for ≥15 min. with or without assistive aid
  • Exclusion Criteria:
  • 1. Cannot comprehend and follow instructions, or with a score \<21 on the mini-mental state exam;
  • 2. Have cardiac pacemaker;
  • 3. Have skin lesions at the locations where FES or EMG electrodes may be attached;
  • 4. Have major depression;
  • 5. Present with severe neglect
  • 6. Patients with type i and ii diabetes

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials